In this analysis, 61.5% (24/39) of pancreatic cancer samples had at least a 1.5-fold increase in RUNX1 mRNA expression levels relative to normal samples (P=0.001) (Figure 1C). The gene discussed is RUNX1; the disease is familial pancreatic carcinoma.